Heavyweight index adjustment “eye grass” and others were kicked out, and the list of performance pre increased constituent stocks was released

FTSE Russell announced the adjustment of FTSE China 50 index, FTSE China A50 Index and other indexes.

the first domestic recombinant covid-19 virus protein vaccine was approved with conditions

In March 1st, the State Drug Administration approved the registration application of recombinant New Coronavirus protein vaccine of Anhui Zhi Fei Long Ma Biological Pharmaceutical Co., Ltd. this vaccine is the first approved domestic recombinant COVID-19 virus protein vaccine, which is suitable for preventing diseases caused by New Coronavirus infection.

Chongqing Zhifei Biological Products Co.Ltd(300122) announced that the recombinant COVID-19 protein vaccine is the first approved recombinant COVID-19 virus protein vaccine, which is suitable for preventing New Coronavirus infection caused diseases (COVID-19). The company will continue to do a good job in the production and supply of the vaccine with quality and quantity. If the follow-up work goes smoothly, it will promote the WHO certification of the vaccine and strengthen the vaccination as a sequential (heterologous) vaccination, and will also have a positive impact on the future performance, R & D progress and internationalization strategy of the listed company.

It is understood that the covid-19 vaccine that has been approved to go on the market in China at the moment, as it is understood that the covid- 19 vaccine that has been approved to go on the market in China at the moment, the covid- 19 vaccine that is currently the covid- 19 vaccine that is the covid- 19, the covid-19 vaccine that has been approved to the market in China is currently being understood that the covid-19 vaccine that has been approved to go on the market in China. The main types of the covid- 19 vaccine that has been approved to go on the market in China are the three types, which are the three types of the three types that have been approved to go on the market in China at the moment. At the moment, the covid (Beijing Institute, Wuhan Institute, Wuhan Institute, and sinosinosinosinosinosinosinosinotech, which is being, which is being, and Wuhan Institute of Wuhan Institute, and sinosinosinosinosinosinosinosinotech, which is, which is being, the are all A-share listed companies. The profits of the three listed companies increased significantly under the influence of the rapid and large volume of covid-19 vaccine. Among A-share listed companies, vaccines of Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) , Walvax Biotechnology Co.Ltd(300142) , Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) and other companies are under development.

Shenzhen Kangtai Biological Products Co.Ltd(300601) performance forecast shows that the net profit attributable to the parent company is expected to be 1.2-1.4 billion yuan in 2021, with a year-on-year increase of 76.68% – 106.13%. Cansino Biologics Inc(688185) biological performance express shows that the net profit attributable to the parent company is 1.914 billion yuan, with a year-on-year turn from loss to profit. The company may make its first profit Chongqing Zhifei Biological Products Co.Ltd(300122) vaccine has previously obtained emergency use authorization overseas. The company expects to realize a net profit attributable to the parent company of 10.197 billion yuan in 2021, with a year-on-year increase of 208.88%.

Covid-19 vaccine concept stocks continued to callback for nearly half a year. Statistics show that since the second half of last year, covid-19 vaccine concept stocks have fallen by an average of 30.56%, the withdrawal degree of Cansino Biologics Inc(688185) -u is close to 70%, and Shenzhen Kangtai Biological Products Co.Ltd(300601) , Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) , etc. have also decreased significantly.

Recently, with the approval of the joint prevention and control mechanism of the State Council, the National Health Commission has begun to deploy sequential immunization. After the implementation of the sequential booster immunization strategy, the target population of covid-19 virus inactivated vaccine of Sinopharm Zhongsheng Beijing company, Beijing Kexing company and Sinopharm Zhongsheng Wuhan company can also choose Zhifei recombinant protein vaccine or Cansino Biologics Inc(688185) adenovirus vector vaccine for sequential booster immunization. As of February 18, a total of 307572 billion doses of covid-19 virus vaccine had been reported in China, and the number of people who had completed the whole process of vaccination was 123543 billion.

latest adjustment of FTSE China A50 Index

On March 2, FTSE Russell announced the index review changes of FTSE China 50 index, FTSE China A50 Index, FTSE China a150 index, FTSE China A200 index, FTSE China a400 index and FTSE China a small cap stock index. It is reported that the change will come into effect on Monday, March 21, 2022.

In this adjustment of the constituent stocks of FTSE China A50 Index, will be included in Bank Of Ningbo Co.Ltd(002142) , China State Construction Engineering Corporation Limited(601668) , Postal Savings Bank Of China Co.Ltd(601658) same as delete Aier Eye Hospital Group Co.Ltd(300015) , China Life Insurance Company Limited(601628) , Eve Energy Co.Ltd(300014) . In addition, FTSE Russell also announced the list of alternative stocks for the new quarter, which will take effect immediately. If one or more component stocks are deleted before the review of component stocks in the next quarter, alternative stocks will be selected. These stocks are Anhui Conch Cement Company Limited(600585) , China Citic Bank Corporation Limited(601998) , Rongsheng Petro Chemical Co.Ltd(002493) , Will Semiconductor Co.Ltd.Shanghai(603501) , Yunnan Energy New Material Co.Ltd(002812) .

Among the constituent stocks deleted this time, Eve Energy Co.Ltd(300014) was newly included on December 1 last year and was eliminated after only one quarter Eve Energy Co.Ltd(300014) reached the highest price in history on November 29 last year, and then was newly incorporated into the constituent stocks. After joining, the stock price performance is not satisfactory. Since December 1, Eve Energy Co.Ltd(300014) has fallen by 42.4% in total, ranking the first among all constituent stocks.

In contrast, the newly added concept stocks have performed well since December, China State Construction Engineering Corporation Limited(601668) has risen by 12.07%, ranking the eighth among all constituent stocks, and Postal Savings Bank Of China Co.Ltd(601658) has risen by 11.42%, the highest among constituent stocks Bank Of Ningbo Co.Ltd(002142) is the regional bank with the largest total market value among A-Shares and the first bank stock to be selected into the FTSE China A50 Index.

list of constituent stocks with pre increased performance released

FTSE China A50 Index selects the highest total market value of A-Shares and QFII can be held as the main stock selection rules, covering all walks of life, and represents the overall performance of A-Shares to a certain extent. According to the statistics of securities times · databao, according to the adjusted list, there are 7 listed companies with a total market value of more than trillion, and the total market value of other stocks is more than 200 billion yuan except Chongqing Zhifei Biological Products Co.Ltd(300122) .

Statistics show that 24 of the constituent stocks have announced the performance forecast or performance express for 2021, of which 21 have increased in advance. In terms of the median expected increase in net profit, Cosco Shipping Holdings Co.Ltd(601919) , Petrochina Company Limited(601857) , Chongqing Zhifei Biological Products Co.Ltd(300122) is expected to rank first, with 799.3%, 384.5% and 208.88% respectively.

The constituent stocks are popular among overseas investors. The majority shares are favored by overseas investors. Statistics show that QFII holds a total of 114506 billion yuan of shares with a total of 114506 billion yuan in QFII’s total stake of 114506 billion yuan as of September 30, 2021. Statistics show that as of September 30, 2021, QFII holds a total of 1145006 billion yuan, with 456 \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ 123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123123and Gree Electric Appliances Inc.Of Zhuhai(000651) hold the highest stock market value.

- Advertisment -